For Patients | News | Contact Us




Case Studies

Case Study 1:

Stage 3 Sacral Pressure Ulcer in an 82-year-old Male

Case Study 1

full case study
 
 

Case Study 2:

Surgical Wound in a 76-year-old Female with Multiple Comorbidities

Case Study 2

 

full case study

 

 
 

Case Study 3:

Unstageable, Non-healing Pressure Ulcer in an 88-year-old Female

Case Study 3

 

full case study

 

 
 
Interactive Series

Collagenase SANTYL® Ointment is indicated for debriding chronic dermal ulcers and severely burned areas. Occasional slight transient erythema has been noted in surrounding tissue when applied outside the wound. One case of systemic hypersensitivity has been reported after 1 year of treatment with collagenase and cortisone.
Use of Collagenase SANTYL® Ointment should be terminated when debridement is complete and granulation tissue is well established.
See complete prescribing information for more details.

Mechanism of Action Video

moa video
Application Protocol for
SANTYL® Ointment

learn more link
FAQs

Answers to Frequently Asked
Questions About SANTYL®
Ointment
learn more link
Healthpoint and SANTYL are registered trademarks of Healthpoint, Ltd.
© 2011 Healthpoint Biotherapeutics. All rights reserved.
The information on this site is intended for customers, patients, and healthcare professionals in the United States only. All information, including the Prescribing Information for Collagenase SANTYL® Ointment, abides by the laws, regulatory requirements, and medical practices for the United States only and may not be appropriate for use outside of the United States.